当前位置:首页 - 行情中心 - 华仁药业(300110) - 财务分析

华仁药业

(300110)

  

流通市值:39.78亿  总市值:39.84亿
流通股本:11.80亿   总股本:11.82亿

华仁药业(300110)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.41亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益271321.85万元,未分配利润85578.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产517184.13万元,负债245862.29万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,215,927,751.99829,046,309.5403,241,817.911,619,492,335.02
营业总成本1,032,296,689.68720,954,485.3349,719,742.041,397,144,045.46
营业利润154,749,072.0488,435,618.6846,679,557.32198,490,746.68
利润总额157,214,089.0790,717,752.6646,751,754.94205,859,090.86
净利润140,650,990.5184,438,182.9941,870,660.5181,337,643.24
其他综合收益----
综合收益总额140,650,990.5184,438,182.9941,870,660.5181,337,643.24
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计2,800,949,280.782,930,145,745.62,748,997,200.092,729,564,066.66
非流动资产合计2,370,892,066.52,386,570,390.332,389,161,533.622,432,951,182.98
资产总计5,171,841,347.285,316,716,135.935,138,158,733.715,162,515,249.64
流动负债合计1,743,150,283.531,952,174,280.981,812,931,005.532,029,430,783.45
非流动负债合计715,472,569.3707,542,630.97683,590,793.32533,318,191.83
负债合计2,458,622,852.832,659,716,911.952,496,521,798.852,562,748,975.28
归属于母公司股东权益合计2,643,149,109.762,588,340,944.112,571,988,434.252,530,885,547.84
股东权益合计2,713,218,494.452,656,999,223.982,641,636,934.862,599,766,274.36
负债和股东权益合计5,171,841,347.285,316,716,135.935,138,158,733.715,162,515,249.64
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计1,383,074,109.47959,756,195.17422,618,103.21,691,194,596.17
经营活动现金流出小计1,186,015,299.85834,105,612.78355,619,459.451,473,210,534.53
经营活动产生的现金流量净额197,058,809.62125,650,582.3966,998,643.75217,984,061.64
投资活动现金流入小计10,327,200.3410,327,200.34-26,518,151.41
投资活动现金流出小计95,580,665.1785,762,555.7871,050,197.34170,329,618.67
投资活动产生的现金流量净额-85,253,464.83-75,435,355.44-71,050,197.34-143,811,467.26
筹资活动现金流入小计1,384,906,6821,093,048,000425,000,0002,119,658,775.38
筹资活动现金流出小计1,487,054,633.771,015,876,746.89416,238,961.452,272,328,483
筹资活动产生的现金流量净额-102,147,951.7777,171,253.118,761,038.55-152,669,707.62
汇率变动对现金及现金等价物的影响-1,970.06-272.56-391.44-895.71
现金及现金等价物净增加额9,655,422.96127,386,207.54,709,093.52-78,498,008.95
期末现金及现金等价物余额153,785,489.06271,516,273.6148,839,159.62144,130,066.1
TOP↑